Key Points
- Director Howard Slayen sold 5,700 Aehr Test Systems shares at an average price of $133.03, generating $758,271 and reducing his holdings by 3.89% to 140,667 shares.
- AEHR opened at $134.06 and remains near its 52-week high of $147.40, with a $4.37 billion market capitalization and elevated valuation metrics.
- Despite insider selling, analysts maintain an overall “Buy” rating with an average price target of $136.67; the company is also benefiting from AI-related demand, including a $22 million follow-on order, record bookings and a sizable backlog.
Aehr Test Systems (NASDAQ:AEHR - Get Free Report) Director Howard Slayen sold 5,700 shares of the firm's stock in a transaction on Friday, August 14th. The shares were sold at an average price of $133.03, for a total transaction of $758,271.00. Following the sale, the director owned 140,667 shares in the company, valued at approximately $18,712,931.01. This trade represents a 3.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Aehr Test Systems Price Performance
Shares of NASDAQ AEHR opened at $134.06 on Friday. Aehr Test Systems has a 1 year low of $16.38 and a 1 year high of $147.40. The stock has a market capitalization of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10. The company's 50-day moving average is $92.83 and its 200 day moving average is $71.45.
Hedge Funds Weigh In On Aehr Test Systems
Large investors have recently bought and sold shares of the business. Caitong International Asset Management Co. Ltd bought a new position in Aehr Test Systems during the 4th quarter worth about $25,000. Advocate Investing Services LLC bought a new position in shares of Aehr Test Systems during the 2nd quarter worth approximately $26,000. Sunbelt Securities Inc. purchased a new stake in Aehr Test Systems during the third quarter valued at approximately $27,000. State of Wyoming acquired a new stake in Aehr Test Systems in the second quarter valued at approximately $28,000. Finally, KBC Group NV purchased a new position in Aehr Test Systems in the first quarter worth $30,000. Hedge funds and other institutional investors own 69.69% of the company's stock.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the company. Zacks Research raised Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a report on Friday, July 17th. Wall Street Zen upgraded shares of Aehr Test Systems from a "sell" rating to a "hold" rating in a report on Saturday, July 18th. Lake Street Capital reaffirmed a "buy" rating and issued a $110.00 target price on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Freedom Capital upgraded shares of Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a research note on Thursday, July 16th. Finally, Weiss Ratings lowered shares of Aehr Test Systems from a "sell (d)" rating to a "sell (e+)" rating in a research note on Wednesday, July 29th. Three equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Aehr Test Systems currently has an average rating of "Buy" and an average target price of $136.67.
Read Our Latest Stock Analysis on AEHR
Key Headlines Impacting Aehr Test Systems
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
- Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation
Aehr Test Systems Company Profile
(
Get Free Report)
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
